Apple to roll out hypertension detection on smart watch after FDA nod
Feature will be available on Apple Watch Series 9, Series 10, Series 11, and Ultra 2 and Ultra 3 smartwatches
Apple is set to unveil the latest hypertension detection feature in its smartwatch by next week, after Food and Drug Administration (FDA) clearance on Thursday, Bloomberg News reported.
Apple and the FDA did not immediately respond to Reuters' requests for comment.
The company unveiled a blood pressure monitor in its latest Apple Watch at the September 9 event, where it also introduced a refreshed iPhone lineup, including a slimmer iPhone Air.
The feature, pending regulatory approval, will not detect every case of high blood pressure, but could alert about a million people, Apple said.
Available in 150 countries, the tool will use data from the watch's optical heart sensor to track how a user's blood vessels respond to heartbeats over 30 days, the report said, citing Apple.
The feature will be available on the Apple Watch Series 9, Series 10, Series 11, and its more expensive Ultra 2 and Ultra 3 smartwatches, Bloomberg News said.
-
Natural selection still at work: Red hair genes increasing, study finds -
Scientists uncover the ‘acquired habit’ behind the human handedness puzzle -
Comet 3I/ATLAS could help protect Earth, scientists say -
Scientists detect strange patterns that may signal alien life -
Rare ‘God of chaos’ asteroid will be visible to naked eye in historic flyby, says NASA -
What is Cygnus XL: Will NASA’s ISS cargo ship return to Earth? -
Where were the first animals? Scientists discover rare fossil -
Elon Musk vs Jeff Bezos: Who will reach the Moon first in new space race?
